Cancer Research Communications: 2023, vol: 3, issue: 12
- 1)- Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, Ching-Heng Chou, Clifford S Guy, Michaela Meehl, Zhongzhen Yi, Scott Perry, Jonathan Laxton, Trevor Cunningham, Deanna Langfitt, Peter Vogel, Christopher DeRenzo, Stephen Gottschalk, Martine F Roussel, Paul G Thomas, Giedre Krenciute. CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity. Cancer research communications. 2023, 3 (12): 2430-2446
Cited : 4Read More - 2)- Paul B Chapman, Mark Klang, Michael A Postow, Alexander Noor Shoushtari, Ryan J Sullivan, Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Phillip Wong, Margaret K Callahan, Bin Zheng, Jonathan Zippin. Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib. Cancer research communications. 2023, 3 (12): 2447-2454Cited : 1Read More
- 3)- Andrea R Daniel, Chang Su, Nerissa T Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R Selitsky, Jennifer L Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M Mowery, Diana M Cardona, Chang-Lung Lee, David G Kirsch. Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas. Cancer research communications. 2023, 3 (12): 2455-2467Cited : 0Read More
- 4)- Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, Margarita Raygada, Robin Lockridge, John W Glod, Crystal Flowers, B J Thomas, Donna B Bernstein, Oxana B Kapustina, Ashish Jain, Markku Miettinen, Mark Raffeld, Liqiang Xi, Manoj Tyagi, Jung Kim, Kenneth Aldape, Ashkan A Malayeri, Rosandra N Kaplan, Taryn Allen, Christina A Vivelo, Abby B Sandler, Brigitte C Widemann, Karlyne M Reilly, . Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. Cancer research communications. 2023, 3 (12): 2468-2482Cited : 0Read More
- 5)- William Echavidre, Jérôme Durivault, Célia Gotorbe, Thays Blanchard, Marina Pagnuzzi, Valérie Vial, Florian Raes, Alexis Broisat, Rémy Villeneuve, Régis Amblard, Nicolas Garnier, Cécile Ortholan, Marc Faraggi, Benjamin Serrano, Vincent Picco, Christopher Montemagno. Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance. Cancer research communications. 2023, 3 (12): 2483-2496Cited : 1Read More
- 6)- Dennis Juarez, Roberta Buono, Shannon M Matulis, Vikas A Gupta, Madeleine Duong, Jacob Yudiono, Madhuri Paul, Sharmila Mallya, Grace Diep, Peter Hsin, Alexander Lu, Sang Mi Suh, Vy M Dong, Andrew W Roberts, Joel D Leverson, Muhammad Jalaluddin, Zhuangzhuang Liu, Orlando F Bueno, Lawrence H Boise, David A Fruman. Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Cancer research communications. 2023, 3 (12): 2497-2509Cited : 1Read More
- 7)- Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria S Higbie, Kanwal P S Raghav, Benny Johnson, Arvind Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Scott Kopetz, Michael J Overman, Van Karlyle Morris. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications. 2023, 3 (12): 2510-2517Cited : 2Read More
- 8)- Debarshi Banerjee, Shuobo Boboila, Shunpei Okochi, James M Angelastro, Angela V Kadenhe-Chiweshe, Gonzalo Lopez, Andrea Califano, Eileen P Connolly, Lloyd A Greene, Darrell J Yamashiro. Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer research communications. 2023, 3 (12): 2518-2530Cited : 2Read More
- 9)- Emanuela Gentile, Andrew W Hahn, Jian H Song, Anh Hoang, Peter D A Shepherd, Sumankalai Ramachandran, Nora M Navone, Eleni Efstathiou, Mark Titus, Paul G Corn, Sue-Hwa Lin, Christopher J Logothetis, Theocharis Panaretakis. Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer. Cancer research communications. 2023, 3 (12): 2531-2543Cited : 1Read More
- 10)- Raymond W Hughley, Marco Matejcic, Ziwei Song, Xin Sheng, Peggy Wan, Lucy Xia, Steven N Hart, Chunling Hu, Siddhartha Yadav, Alexander Lubmawa, Vicky Kiddu, Frank Asiimwe, Colline Amanya, George Mutema, Kuteesa Job, Mbaaga K Ssebakumba, Sue A Ingles, Ann S Hamilton, Fergus J Couch, Stephen Watya, David V Conti, Burcu F Darst, Christopher A Haiman. Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry. Cancer research communications. 2023, 3 (12): 2544-2550Cited : 0Read More
- 11)- Vikram Malhi, Priya Agarwal, Mary R Gates, Lichuan Liu, Jianshuang Wang, Tom De Bruyn, Scott Lam, Jennifer Eng-Wong, Pablo Perez-Moreno, Ya-Chi Chen, Jiajie Yu. Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer. Cancer research communications. 2023, 3 (12): 2551-2559Cited : 2Read More
- 12)- Tarek H Mouhieddine, Chidimma Nzerem, Robert Redd, Andrew Dunford, Matthew Leventhal, Romanos Sklavenitis-Pistofidis, Sabrin Tahri, Habib El-Khoury, David P Steensma, Benjamin L Ebert, Robert J Soiffer, Jonathan J Keats, Shaadi Mehr, Daniel Auclair, Irene M Ghobrial, Adam S Sperling, Chip Stewart, Gad Getz. Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma. Cancer research communications. 2023, 3 (12): 2560-2571Cited : 2Read More
- 13)- Pamela Munster, Nicholas Iannotti, Daniel C Cho, John M Kirkwood, Liza C Villaruz, Geoffrey T Gibney, F Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day. Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications. 2023, 3 (12): 2572-2584Cited : 3Read More
- 14)- Ferdynand J Kos, Paul Frankel, Mihaela Cristea, Melissa Eng, Raechelle Tinsley, Shannon Dempsey, Nora Ruel, Daphne Stewart, Thanh H Dellinger, Don J Diamond. Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer. Cancer research communications. 2023, 3 (12): 2585-2595Cited : 1Read More
- 15)- Siobhan O'Brien, Tajinder Ubhi, Lucie Wolf, Krishna Gandhi, Sichun Lin, Naz Chaudary, Neesha C Dhani, Michael Milosevic, Grant W Brown, Stephane Angers. FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. Cancer research communications. 2023, 3 (12): 2596-2607Cited : 3Read More
- 16)- Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Adam Shlien, Madeline N Hayes, Meredith S Irwin. SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma. Cancer research communications. 2023, 3 (12): 2608-2622Cited : 0Read More
- 17)- Aslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V, Bogos Agianian, Martin Garcia Chavez, Vignesh Vudatha, Rui Wang, Rajanikanth Vangipurapu, Liwei Chen, Perry Kennedy, Karthikeyan Subramanian, Jonathan C K Quirke, Francisca Beato, Patrick W Underwood, Jason B Fleming, Jose Trevino, Paul J Hergenrother, Evripidis Gavathiotis, Said M Sebti. Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors. Cancer research communications. 2023, 3 (12): 2623-2639Cited : 2Read More
- 18)- Denada Dibra, Mihai Gagea, Yuan Qi, Gilda P Chau, Xiaoping Su, Guillermina Lozano. p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis. Cancer research communications. 2023, 3 (12): 2640-2652Cited : 0Read More
